Content by National Institute of Allergy and Infectious Diseases
Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new treatments and vaccines
| 3 min read
Data from phase 3 clinical trial confirm vaccine is effective, and investigators identified no safety concerns
| 3 min read
Global network to focus on spillover potential
| 2 min read
Multi-site trial to test candidate developed by Moderna and NIH
| 4 min read
Study results provide key information about the stability of SARS-CoV-2, which causes COVID-19 disease
| 2 min read
Study leaders publish results from NIH-DRC-WHO clinical trial of four experimental therapies
| 5 min read
Continuing with a modest dose confers more protection, NIH-funded study finds
| 2 min read
Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer, and other diseases
| 2 min read
NIH scientists suspect process aims to curb immune-system hyperactivity
| 2 min read
NIAID-funded study examines shedding in 320 households during three flu seasons
| 2 min read
The incidence of tickborne infections in the United States has risen significantly within the past decade
| 2 min read
Page 1 of 1 - 11 Total Items
